All posts by: Michael Zand

About Michael Zand

New Law Opens Door for Stem Cell Therapy in Texas – Spectrum News

Continue reading

2017-06-15 NEWS

Spectrum News

New Law Opens Door for Stem Cell Therapy in Texas
Spectrum News
“This is going to protect patient health, and provide for the treatments to be done here locally at home,” said Mike Byrom, the Chief Science Officer at Austin stem cell bank BioEden​. Byrom said the new law will keep patients in the country, and will

Continue reading

2017-06-15 NEWS

KING5.com

Cancer immunotherapy used to treat blood cancer | KING5.com
KING5.com
The re-engineering of a person’s car T cells to fight cancer in their body has become a promising tool for forms of blood cancer. Researchers and doctors hope it …

and more »

Continue reading

2017-06-14 NEWS

Healthline

Is Human Embryonic Stem Cell Research in Jeopardy?
Healthline
In 2010, when renowned stem cell scientist Lawrence Goldstein, PhD, published his groundbreaking book “Stem Cells for Dummies,” with co-author Meg Schneider, the forecast for human embryonic stem cell research had just begun to brighten. In 2001 …
A New Generation of Stem Cell Therapy Launches To The PublicDigital Journal

all 4 news articles »

Continue reading

2017-06-14 NEWS

Healthline

Is Human Embryonic Stem Cell Research in Jeopardy?
Healthline
In 2010, when renowned stem cell scientist Lawrence Goldstein, PhD, published his groundbreaking book “Stem Cells for Dummies,” with co-author Meg Schneider, the forecast for human embryonic stem cell research had just begun to brighten. In 2001 …
A New Generation of Stem Cell Therapy Launches To The PublicDigital Journal

all 4 news articles »

Continue reading

2017-06-14 NEWS

Gene therapy by the numbers
BioPharma Dive
Gene therapies have been in clinical development for decades, a winding, stop-and-start path toward transforming science’s understanding of the genome into commercial therapies. Strimvelis, a gene therapy made by the British pharma GlaxoSmithKline and …

Continue reading

2017-06-14 NEWS

Alternative pricing models a fantasy for gene therapies?
BioPharma Dive
Once upon a time, gene therapy was thought to be the miracle of science that was going to change everything. After safety issues and patient deaths, that didn’t work out quite like the industry had hoped. Yet, 20 years later, the next generation of